Notes
see PharmacoEconomics & Outcomes News 667 p14; 801085622
Reference
NICE. NICE says yes to treatment for asthma in final draft guidance. Media Release : 7 Mar 2013. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE U-turns on omalizumab for asthma. PharmacoEcon Outcomes News 674, 10 (2013). https://doi.org/10.1007/s40274-013-0257-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0257-1